JD.com, Inc. (NASDAQ: JD), a leading technology and service provider in supply chain and e-commerce, reported its unaudited financial results for the second quarter and interim of 2024. The company saw a 1.2% year-over-year increase in net revenues, reaching RMB291.4 billion (US$40.1 billion). Income from operations rose to RMB10.5 billion (US$1.4 billion), marking a 27.0% increase from the previous year. Net income attributable to ordinary shareholders significantly increased by 92.1% to RMB12.6 billion (US$1.7 billion). The company also reported a robust operating cash flow of RMB74.0 billion (US$10.2 billion), a 40.9% increase from the previous year, and a free cash flow of RMB55.6 billion (US$7.7 billion), up by 66.2%. JD.com's share repurchase program was active, with a total of 136.8 million Class A ordinary shares repurchased...Show More

JD.com, Inc. (NASDAQ: JD), a leading technology and service provider in supply chain and e-commerce, reported its unaudited financial results for the second quarter and interim of 2024. The company saw a 1.2% year-over-year increase in net revenues, reaching RMB291.4 billion (US$40.1 billion). Income from operations rose to RMB10.5 billion (US$1.4 billion), marking a 27.0% increase from the previous year. Net income attributable to ordinary shareholders significantly increased by 92.1% to RMB12.6 billion (US$1.7 billion). The company also reported a robust operating cash flow of RMB74.0 billion (US$10.2 billion), a 40.9% increase from the previous year, and a free cash flow of RMB55.6 billion (US$7.7 billion), up by 66.2%. JD.com's share repurchase program was active, with a total of 136.8 million Class A ordinary shares repurchased for US$2.1 billion in the second quarter, and 224.3 million shares for US$3.3 billion in the first half of 2024. Strategic partnerships with brands like Xiaomi, Lenovo, and OPPO were formed, and luxury brands such as MONCLER and alexanderwang were onboarded. JD Health partnered with pharmaceutical companies to debut new drugs online, and JD Logistics continued to optimize its network for improved profitability. The company appointed Ms. Grace Kun Ding and Ms. Jennifer Ngar-Wing Yu as independent directors, effective from August 14, 2024.